当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2010年第16期 > 正文
编号:11956691
中药方治疗老年维持性血液透析患者顽固性便秘的疗效观察与护理(1)
http://www.100md.com 2010年6月5日 刘文凯,谢素琼
第1页

    参见附件(1415KB,2页)。

     [摘要] 目的:探讨中药方治疗老年维持性血液透析患者顽固性便秘的疗效观察与护理。方法:将接受维持性血液透析的50例老年便秘患者随机分为治疗组25例和对照组25例。对照组服用清宁丸、番泻叶、生大黄等通便药,治疗组服用自制中药方。比较两组患者治疗及护理后的临床疗效,并探讨护理要点。结果:治疗后两组症状均有不同程度的改善,治疗组治愈率优于对照组(P<0.05),治疗组总有效率优于对照组(P<0.01)。结论:运用自制中药方治疗老年维持性血液透析患者顽固性便秘可以明显改善患者的便秘症状,且无明显不良反应,值得临床推广。

    [关键词] 血液透析;便秘;中药方

    [中图分类号] R473.5[文献标识码]C [文章编号]1673-7210(2010)06(a)-114-02

    Observation on efficacy of Chinese prescription medicine cure constipation in maintenance hemodialysis old patients and nursing

    LIU Wenkai, XIE Suqiong

    (Xixiang People′s Hospital, Bao′an District of Shenzhen City, Shenzhen518102, China)

    [Abstract] Objective: To explore the efficacy of Chinese prescription medicine cure constipation in maintenance hemodialysis old patients and nursing. Methods: Received maintenance hemodialysis patients, 50 elderly patients with constipation, 25 cases were randomly divided into treatment group and control group 25 cases. The control group was given pills, senna, rhubarb and other laxative medicines, the treatment group were taken the prescriptions made. Comparing the two groups after the treatment and care in patients with the clinical efficacy and to explore the care points. Results: After treatment, the two groups had different symptoms improved degree. The recovery rate of treatment group better than in control group(P<0.05), the total effective rate of treatment group better than in control group(P<0.01). Conclusion: Chinese prescription medicine cure constipation in maintenance hemodialysis old patients can obviously improve constipation symptoms, and no obvious adverse reactions, it is worth popularizing.

    [Key words] Hemodiafiltration; Constipation; Chinese prescription medicine

    便秘是老年维持性血液透析患者常见的并发症,严重影响血液透析患者的生活质量,临床处理也较为棘手。本文从2005年9月~2008年9月采用自制中药方对50例老年血透患者便秘进行治疗,取得不错的效果,结果如下:

    1 资料与方法

    1.1 一般资料

    选择2005年9月~2008年9月在我院行血液透析的患者50例,男27例,女23例,年龄68~88岁,平均(75.30±2.75)岁;透析龄2~10年,平均5.4年。其中,治疗组25例,男13例,女12例;对照组25例,男14例,女11例。原发病为慢性肾小球肾炎33例,高血压肾病12例,糖尿病肾病4例,痛风性肾病1例。每周接受血透2~3次,每次4~5 h。所有患者基本能生活自理,排除肠易激综合征及结肠器质性病变。两组患者在年龄、性别、病程等方面差异无统计学意义(P>0.05)。治疗组患者在服用自制中药方前均曾服用过清宁丸、番泻叶、生大黄等药,但疗效皆不明显。

    1.2 诊断标准

    参照罗马标准Ⅱ[1]执行:在过去的12个月内,至少有12周(不必连续)发生以下2项或2项以上的情况者视为便秘:①>1/4的时间里有排便困难;②>1/4的排便为颗粒状或硬便;③>1/4时间中有排便不尽感;④>1/4的排便中有肛门直肠梗阻感;⑤>1/4的排便需人工辅助(如手指抠挖、盆底按摩);⑥排便次数<3次/周,没有排稀便现象,且不能满足肠易激综合征的诊断标准 ......

您现在查看是摘要介绍页,详见PDF附件(1415KB,2页)